Awards & Advancement

SCORR Marketing adds three to team

Friday, June 16, 2017

SCORR Marketing, a global health science marketing and communications firm, announced the addition of three employees with health science marketing expertise, including Lea LaFerla, vice president of marketing services; Edlyn Tobias, marketing technology manager; and James Wang, associate director of business development.

[Read More]

Veeva expands clinical leadership

Tuesday, June 13, 2017

Veeva Systems continues to grow its clinical leadership team with the addition of five industry veterans in clinical operations and clinical data management.

[Read More]

CDISC appoints Shannon Labout interim chief standards officer

Monday, June 12, 2017

David R. Bobbitt, president and CEO at Clinical Data Interchange Standards Consortium (CDISC), appointed Shannon Labout CDISC’s interim chief standards officer. A collaborative leader, dedicated educator and Certified Clinical Data Manager (CCDM), Labout has a proven track record of creating, leading and growing successful organizations in clinical data management, standards implementation and training. In her new role, she will guide the future of standards development, working with CDISC leadership, partners, members and volunteer teams. She will also continue to serve as CDISC’s VP of Education.

[Read More]

Hassman Research Institute appoints Dr. Larry Ereshefsky CSO, Early Phase Development

Tuesday, June 6, 2017

Hassman Research Institute (HRI) announced that Dr. Larry Ereshefsky joined the company as chief scientific officer, Early Phase Development. Dr. Ereshefsky brings to HRI more than 40 years of drug discovery and development experience including leadership roles at University of Texas Health Science and Parexel. Dr. Ereshefsky will be responsible for leading HRI’s efforts and advancing the company’s Early Phase Development Division focusing on diseases. He will report to Dr. Howard Hassman, CSO of HRI.

[Read More]

Alexion adds Orloff, Law and Franchini to leadership team

Monday, June 5, 2017

Alexion Pharmaceuticals announced key additions to its executive leadership team. Reporting to Chief Executive Officer Ludwig Hantson will be: John Orloff, M.D., executive vice president, head of Research & Development; Anne-Marie Law, executive vice president, chief human resources officer; and Indrani Lall Franchini, J.D., executive vice president, chief compliance officer.

[Read More]